SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0000950170-23-042819
Filing Date
2023-08-15
Accepted
2023-08-15 16:29:03
Documents
1
Period of Report
2023-08-15
Effectiveness Date
2023-08-15

Document Format Files

Seq Description Document Type Size
1 NT 10-Q impl-nt10q-20230815.htm NT 10-Q 75584
  Complete submission text file 0000950170-23-042819.txt   76735
Mailing Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. W SUITE 260 SEATTLE WA 98119 206-568-1466
IMPEL PHARMACEUTICALS INC (Filer) CIK: 0001445499 (see all company filings)

IRS No.: 263058238 | State of Incorp.: DE | Fiscal Year End: 0426
Type: NT 10-Q | Act: 34 | File No.: 001-40353 | Film No.: 231175253
SIC: 2834 Pharmaceutical Preparations